Skip to main content
. 2018 Jul 9;56(2):92–98. doi: 10.5152/npa.2017.22660

Table 1.

Clinical properties of the patients

Patient Age, sex DNP HNP Pain duration (months) VAS (0–100 mm) PD-Q (0–38) HbA1 c SMMT
1 51, F + 6 60 18 8.4 30
2 52, M + 12 50 21 6.8 29
3 50, M + 120 90 19 11.4 29
4 54, F + 30 80 22 8.9 24
5 37, M + 15 70 23 6.3 30
6 46, M + 18 70 20 6.8 30
7 58, F + 24 90 21 5.7 26
8 38, M + (HMSN1) 0 0 6 29
9 36, F + (HMSN1) 48 40 11 28
10 19, M + (HMSN1) 0 0 6 28
11 31, F + (HMSN2) 0 0 9 26
12 47, M + (HMSN1) 12 30 11 30
13 19, M + (HSN) 42 30 13 30
14 40, F + (HMSN1) 0 0 0 30
15 64, M + (HMSN1) 0 0 0 29
16 45, F + 48 70 19 6.3 30
17 53, F + 6 60 23 5.8 29
18 52, F + (HMSN1) 12 60 . .
19 32, M + (HMSN1) 0 0 0 .
20 55, M + 12 50 18 6.5 29

DNP, diabetic neuropathy; HNP, hereditary neuropathy; HMSN, hereditary motor and sensory neuropathy; SMMT, standardized mini-mental test; HSN, hereditary sensory neuropathy; VAS, visual analogue scale; PD-Q, painDETECT questionnaire; F, female M, male